Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Non-cash Items (2016 - 2020)

Myriad Genetics (MYGN) has disclosed Non-cash Items for 11 consecutive years, with $4.8 million as the latest value for Q2 2020.

  • Quarterly Non-cash Items changed N/A to $4.8 million in Q2 2020 from the year-ago period, while the trailing twelve-month figure was $4.8 million through Jun 2020, changed N/A year-over-year, with the annual reading at $4.8 million for FY2020, N/A changed from the prior year.
  • Non-cash Items for Q2 2020 was $4.8 million at Myriad Genetics, down from $5.5 million in the prior quarter.
  • The five-year high for Non-cash Items was $8.6 million in Q1 2016, with the low at $2.2 million in Q1 2017.
  • Average Non-cash Items over 5 years is $6.0 million, with a median of $6.3 million recorded in 2018.
  • Peak annual rise in Non-cash Items hit 11.94% in 2017, while the deepest fall reached 74.42% in 2017.
  • Over 5 years, Non-cash Items stood at $7.6 million in 2016, then dropped by 1.32% to $7.5 million in 2017, then dropped by 16.0% to $6.3 million in 2018, then dropped by 12.7% to $5.5 million in 2019, then fell by 12.73% to $4.8 million in 2020.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $4.8 million, $5.5 million, and $6.3 million for Q2 2020, Q1 2019, and Q2 2018 respectively.